Imaging services provider InSight Health Services has entered into a radiology cosourcing joint venture with St. Rose Dominican Hospital, part of the Catholic Healthcare West system, and Radiology Associates of Nevada (RAN), a group of 24 board-certified
Imaging services provider InSight Health Services has entered into a radiology cosourcing joint venture with St. Rose Dominican Hospital, part of the Catholic Healthcare West system, and Radiology Associates of Nevada (RAN), a group of 24 board-certified radiologists. The three entities will operate Parkway Imaging Center, a 5800-square-foot multimodality facility located within St. Roses Parkway Medical Plaza in Henderson, NV.
InSight of Newport Beach, CA, expects Parkway to complement its existing multimodality imaging center in Las Vegas, InSight Mountain Diagnostics (IMD). The company chose to partner with St. Rose and RAN since RAN serves St. Rose, IMD, and Parkway.
In other InSight news, the company recorded a 36.1% increase in revenues during its 1999 fiscal year (end-June). Revenues climbed to $162 million, compared with $119 million last year. Net income was $6.1 million, compared with $512,000 in fiscal 1998.
Fourth quarter results were also strong. The firm had revenues of $44.4 million, up 23.7% compared with the $33.9 million posted last year. Net income was $1.9 million, down slightly from $2 million posted in 1998.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.